# Simultaneous Integrated Boost for Mediastinal Lymph Node Recurrence After Radical Surgery of Esophageal Cancer

> **NCT03990532** · NA · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 46 (estimated)

## Conditions studied

- Esophageal Cancer
- Salvage Radiotherapy
- Dose-escalation
- Mediastinal Lymph Node Recurrence

## Interventions

- **RADIATION:** treatment group(phase I)
- **RADIATION:** treatment group (phase II)

## Key facts

- **NCT ID:** NCT03990532
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-30
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2022-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03990532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03990532, "Simultaneous Integrated Boost for Mediastinal Lymph Node Recurrence After Radical Surgery of Esophageal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03990532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*